Trial intelligence / Profile preview

High-dose vs Standard-dose Hepatitis B Vaccine in Methadone Maintenance Patients

NCT02991599Phase 4Completed

Sponsor
Shanxi Medical University
Start
Oct 2014
Primary completion
Jul 2015
Modality
Vaccines & Immunotherapeutics
01

Overview

A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by Shanxi Medical University. Started Oct 2014; status: completed.

02

Drugs

hepatitis b vaccine recombinant
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT02991599.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02991599.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call